Qilan Li

575 total citations
24 papers, 398 citations indexed

About

Qilan Li is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Qilan Li has authored 24 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Epidemiology and 8 papers in Hepatology. Recurrent topics in Qilan Li's work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (8 papers) and Neuroblastoma Research and Treatments (4 papers). Qilan Li is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (8 papers) and Neuroblastoma Research and Treatments (4 papers). Qilan Li collaborates with scholars based in China, United States and Netherlands. Qilan Li's co-authors include John E. Tavis, Yanhua Guo, Qiangsong Tong, Xiaojing Wang, Jianqun Wang, Liduan Zheng, Anpei Hu, Adriaan P. IJzerman, Shuang Cai and Shikai Jin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and FEBS Letters.

In The Last Decade

Qilan Li

22 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qilan Li China 12 221 121 85 84 57 24 398
Eun‐Wie Cho South Korea 14 226 1.0× 56 0.5× 81 1.0× 40 0.5× 26 0.5× 26 423
Toshiaki Tsubota Japan 12 799 3.6× 68 0.6× 73 0.9× 29 0.3× 27 0.5× 12 923
J. Botyánszki Hungary 8 167 0.8× 30 0.2× 13 0.2× 36 0.4× 17 0.3× 15 297
Xiaoyuan Jia China 11 213 1.0× 56 0.5× 44 0.5× 20 0.2× 15 0.3× 31 391
Tatjana Heidebrecht Netherlands 10 388 1.8× 105 0.9× 17 0.2× 12 0.1× 6 0.1× 13 493
Qin Zhu United States 10 376 1.7× 52 0.4× 16 0.2× 16 0.2× 16 0.3× 21 578
Tsung‐Sheng Su Taiwan 13 302 1.4× 125 1.0× 57 0.7× 67 0.8× 29 0.5× 25 545
Elizabeth C. Townsend United States 8 311 1.4× 52 0.4× 22 0.3× 23 0.3× 27 0.5× 24 443
Ayumi Tsukamoto Japan 9 228 1.0× 47 0.4× 43 0.5× 22 0.3× 5 0.1× 23 380
Chunxia Qiao China 12 162 0.7× 20 0.2× 39 0.5× 11 0.1× 32 0.6× 53 371

Countries citing papers authored by Qilan Li

Since Specialization
Citations

This map shows the geographic impact of Qilan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qilan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qilan Li more than expected).

Fields of papers citing papers by Qilan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qilan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qilan Li. The network helps show where Qilan Li may publish in the future.

Co-authorship network of co-authors of Qilan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qilan Li. A scholar is included among the top collaborators of Qilan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qilan Li. Qilan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bradley, Daniel P., Qilan Li, Marvin J. Meyers, et al.. (2025). Discovery of bimodal hepatitis B virus ribonuclease H and capsid assembly inhibitors. PLoS Pathogens. 21(2). e1012920–e1012920. 1 indexed citations
3.
Wang, Jianqun, Xiaojing Wang, Qilan Li, et al.. (2024). circE2F1-encoded peptide inhibits circadian machinery essential for nucleotide biosynthesis and tumor progression via repressing SPIB/E2F1 axis. International Journal of Biological Macromolecules. 280(Pt 1). 135698–135698. 1 indexed citations
4.
Li, Qilan, et al.. (2024). Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9. International Journal of Oncology. 65(4).
5.
Wang, Xiaojing, Yanhua Guo, Guo Chen, et al.. (2023). Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity. Oncogene. 42(36). 2673–2687. 11 indexed citations
6.
Hu, Anpei, Guo Chen, Yanhua Guo, et al.. (2023). Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity. Clinical and Translational Medicine. 13(4). e1235–e1235. 9 indexed citations
7.
Xiao, Wenjing, Jianqun Wang, Xiaojing Wang, et al.. (2022). Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression. Autophagy. 18(11). 2615–2635. 40 indexed citations
8.
Song, Huajie, Jianqun Wang, Xiaojing Wang, et al.. (2022). HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation. Oncogene. 41(17). 2505–2519. 19 indexed citations
9.
Wang, Shuo, Yujie Ren, Qilan Li, et al.. (2022). Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulators. Bioorganic Chemistry. 129. 106192–106192. 9 indexed citations
10.
Li, Qilan, et al.. (2021). A mid-throughput HBV replication inhibition assay capable of detecting ribonuclease H inhibitors. Journal of Virological Methods. 292. 114127–114127. 11 indexed citations
11.
Ma, Yue, Yujie Ren, Srinivasulu Cherukupalli, et al.. (2021). Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitors. European Journal of Medicinal Chemistry. 225. 113780–113780. 16 indexed citations
12.
Wang, Jianqun, Xiaojing Wang, Yanhua Guo, et al.. (2021). Therapeutic targeting of SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression. SHILAP Revista de lepidopterología. 11(11). e588–e588. 38 indexed citations
13.
Li, Qilan, Elena Lomonosova, Maureen J. Donlin, et al.. (2020). Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication. Antiviral Research. 177. 104777–104777. 20 indexed citations
14.
Li, Qilan, et al.. (2019). Divergent synthesis of a thiolate-based α-hydroxytropolone library with a dynamic bioactivity profile. RSC Advances. 9(59). 34227–34234. 10 indexed citations
15.
Lomonosova, Elena, Qilan Li, Ryan P. Murelli, et al.. (2017). Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice. Antiviral Research. 149. 41–47. 31 indexed citations
16.
Lomonosova, Elena, Qilan Li, A. Gupta, et al.. (2017). Inhibition of hepatitis B virus replication by N -hydroxyisoquinolinediones and related polyoxygenated heterocycles. Antiviral Research. 143. 205–217. 48 indexed citations
17.
Peeters, Miriam C., Qilan Li, Gerard J. P. van Westen, et al.. (2014). Domains for activation and inactivation in G protein-coupled receptors – A mutational analysis of constitutive activity of the adenosine A2B receptor. Biochemical Pharmacology. 92(2). 348–357. 9 indexed citations
18.
Peeters, Miriam C., Qilan Li, Gerard J. P. van Westen, & Adriaan P. IJzerman. (2011). Three “hotspots” important for adenosine A2B receptor activation: a mutational analysis of transmembrane domains 4 and 5 and the second extracellular loop. Purinergic Signalling. 8(1). 23–38. 19 indexed citations
19.
Li, Qilan, Kai Ye, Clara C. Blad, et al.. (2006). ZM241385, DPCPX, MRS1706 Are Inverse Agonists with Different Relative Intrinsic Efficacies on Constitutively Active Mutants of the Human Adenosine A2B Receptor. Journal of Pharmacology and Experimental Therapeutics. 320(2). 637–645. 30 indexed citations
20.
Qi, Yipeng, et al.. (2002). The novel endoplasmic reticulum (ER)‐targeted protein HAP induces cell apoptosis by the depletion of the ER Ca2+ stores. FEBS Letters. 529(2-3). 325–331. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eun‐Wie Cho Breakdown of academic impact, for papers by Toshiaki Tsubota Breakdown of academic impact, for papers by J. Botyánszki Breakdown of academic impact, for papers by Xiaoyuan Jia Breakdown of academic impact, for papers by Tatjana Heidebrecht Breakdown of academic impact, for papers by Qin Zhu Breakdown of academic impact, for papers by Tsung‐Sheng Su Breakdown of academic impact, for papers by Elizabeth C. Townsend Breakdown of academic impact, for papers by Ayumi Tsukamoto Breakdown of academic impact, for papers by Chunxia Qiao
Rankless by CCL
2026